COMMUNIQUÉS West-GlobeNewswire

Novelion Therapeutics Announces Presentation of Positive Metreleptin Data at American Diabetes Association Scientific Sessions

25/06/2018 - 14:00

Data Show Leptin Replacement Therapy Sustainably Decreased Weight Over Time in Patients with Low Baseline Leptin Levels Company plans to initiate Phase 2 proof of concept study in hypoleptinemic metabolic disorder (HMD [...]

Immune Design Presents Data on the Mechanism of Action of G100 via TLR4 Expressed in B Cell Malignancies at the Inaugural AACR International Meeting Advances in Malignant Lymphoma

25/06/2018 - 14:00

- G100 directly targets and modifies TLR4 expressing malignant B cells making them more visible to the anti-tumor immune response- SEATTLE and SOUTH SAN FRANCISCO, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Immune Design [...]

Celsion Corporation to Join Russell Microcap® Index

25/06/2018 - 14:00

LAWRENCEVILLE, N.J., June 25, 2018 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that it will be added to the Russell Microcap® Index as part of the [...]

Cannabis Leaf (PCFP) Completes Merger with Apotheca Biosciences – Company’s R & D Focuses on Opioid Crisis, a National Public Health Emergency

25/06/2018 - 13:30

Saint Petersburg, FL, June 25, 2018 (GLOBE NEWSWIRE) -- Cannabis Leaf (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, formulation and cannabis delivery technologies for the healthcare and [...]

Mustang Bio Added to Russell 2000®, 3000® and Microcap® Indexes

25/06/2018 - 13:30

NEW YORK, June 25, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ:MBIO), a Fortress Biotech (NASDAQ:FBIO) Company focused on the development of novel immunotherapies based on proprietary chimeric antigen [...]

Caelum Biosciences Announces Complete Cardiac Data Analysis from Phase 1b Trial of CAEL-101 in AL Amyloidosis

25/06/2018 - 13:30

Nine of 10 cardiac patients on CAEL-101 showed improvement in global longitudinal strain CAEL-101 led to sustained decrease in NT-proBNP levels Data presented at American Society of Echocardiography 29th Annual [...]

PolarityTE Added to Russell 3000® and Russell 2000® Indexes

25/06/2018 - 13:30

SALT LAKE CITY, June 25, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing [...]

ADMA Biologics Added to the Russell 3000 and Russell 2000 Indexes

25/06/2018 - 13:08

RAMSEY, N.J. and BOCA RATON, Fla., June 25, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a vertically integrated commercial biopharmaceutical company that manufactures, markets and develops specialty [...]

Zafgen Set to Join Russell 3000® Index

25/06/2018 - 13:05

BOSTON, June 25, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc., (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary MetAP2 biology platform to develop novel therapies for patients affected by [...]

Novo Nordisk A/S - Share repurchase programme

25/06/2018 - 13:04

Bagsværd, Denmark, 25 June 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]

Medtronic Receives CE Mark for MiniMed(TM) 670G Hybrid Closed Loop System

25/06/2018 - 13:01

DUBLIN - June 25, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received CE (Conformité Européenne) Mark for the MiniMed(TM) 670G hybrid closed loop system - the first [...]

Helius Medical Technologies, Inc. Joins Russell 3000® Index, Russell 2000® Index and Russell Microcap® Index

25/06/2018 - 13:01

NEWTOWN, Pa., June 25, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, announced today that the [...]

EyePoint Pharmaceuticals Announces Stockholder Approval of Second Tranche of Capital Financing

25/06/2018 - 13:00

Expected closing of $25.5 million in capital to be used to accelerate EyePoint’s transformation into a commercial-stage specialty biopharmaceutical company Financing supports two near-term product launches anticipated [...]

Unum Therapeutics Joins Russell 3000® Index

25/06/2018 - 13:00

CAMBRIDGE, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (Nasdaq:UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies based on its novel, universal [...]

Allergy Therapeutics announces publication of data demonstrating long-lasting efficacy of Pollinex Quattro Grass vaccine in Immunotherapy

25/06/2018 - 13:00

Allergy Therapeutics plc (“Allergy Therapeutics” or the “Group”) Allergy Therapeutics announces publication of data demonstrating long-lasting efficacy of Pollinex Quattro Grass vaccine in Immunotherapy 25 June 2018 [...]

BeyondSpring’s Principal Investigator in China for Chemotherapy-Induced Neutropenia Delivered Keynote Presentation at 12th Annual Chinese Symposium on Medical Oncology and 7th Annual Meeting of the Chinese Association for Clinical Oncologists

25/06/2018 - 13:00

China Chairman of NCCN Guidelines for Neutropenia Management, Dr. Yuankai Shi, Presented Positive Clinical Data Update on BeyondSpring’s Lead Asset, Plinabulin NEW YORK, June 25, 2018 (GLOBE NEWSWIRE) -- BeyondSpring [...]

Easton Pharmaceuticals Strengthens its Board of Directors While Enhancing Existing Businesses and Moves Towards New Sectors and Industries

25/06/2018 - 13:00

TORONTO, ON, June 25, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC:EAPH) is pleased to announce the appointment of Mr. Panagis (“Panos”) Alivizatos, to its Board of Directors to enhance existing businesses [...]

International Stem Cell Corporation Publishes Advanced Stem Cell Therapy Methodology in Stem Cells and Development Journal

25/06/2018 - 13:00

CARLSBAD, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]

REMINDER: Zafgen to Host ZGN-1061 Phase 2 Data Conference Call

25/06/2018 - 13:00

BOSTON, June 25, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. , (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company using its proprietary knowledge of MetAP2 systems biology to help patients affected by a range of [...]